查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386605

醫療仿生市場報告：2030 年趨勢、預測與競爭分析

Medical Biomimetics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫學仿生學的趨勢與預測

預計到 2030 年，全球醫學仿生市場將達到約 566 億美元，2024 年至 2030 年年複合成長率為 7.0%。該市場的主要驅動力是政府增加對生物識別研究的投資以及醫療保健領域機械工程和奈米技術的整合和進步。全球醫療仿生市場的未來前景廣闊，醫院和專科中心市場蘊藏商機。

醫學仿生市場洞察

Lucintel 預測，由於牙齒問題發生率的增加和牙科仿生產品的高採用率，牙科預計在預測期內將經歷最高的成長。

在這個市場中，由於手術病例的增加和全球慢性病盛行率的上升，創傷治療可能仍然是最大的部分。

由於需要使用牙科仿生產品的牙科問題的增加以及政府對仿生產品研究的資助增加，北美在預測期內可能仍然是最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 哪些細分市場最有前景且成長潛力最大？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球醫療仿生市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球醫學仿生市場趨勢（2018-2023）與預測（2024-2030）
  • 按疾病類型分類的全球醫學仿生市場
    • 心血管
    • 整形外科
    • 眼科
    • 牙科
    • 其他
  • 全球醫療仿生市場應用
    • 創傷治療
    • 人體組織工程
    • 藥物輸送
    • 其他
  • 按最終用途分類的全球醫療仿生市場
    • 醫院
    • 專業中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球醫療仿生市場區域分佈
  • 北美醫療仿生市場
  • 歐洲醫學仿生市場
  • 亞太醫療仿生市場
  • 其他區域醫療仿生市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按疾病類型分類的全球醫學仿生市場成長機會
    • 全球醫療仿生學市場成長機會（按應用）
    • 全球醫療仿生市場最終用途的成長機會
    • 按地區分類的全球醫療仿生市場成長機會
  • 全球醫學仿生市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球醫學仿生市場的產能
    • 全球醫學仿生市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • AVINENT
  • BioHorizons
  • Blatchford
  • CorNeat Vision
  • Curasan
  • Keystone Dental
  • Osteopore International
  • Otsuka Medical Devices
  • Swedish Biomimetics
  • Zimmer Biomet
簡介目錄

Medical Biomimetics Trends and Forecast

The future of the global medical biomimetics market looks promising with opportunities in the hospital and specialty centre markets. The global medical biomimetics market is expected to reach an estimated $56.6 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are increasing government investment in biometrics research, coupled with the integration, and advancement of mechanical engineering and nanotechnology in the healthcare sector.

A more than 150-page report is developed to help in your business decisions.

Medical Biomimetics by Segment

The study includes a forecast for the global medical biomimetics by disease type, application, end use, and region.

Medical Biomimetics Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Others

Medical Biomimetics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Others

Medical Biomimetics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Centres
  • Others

Medical Biomimetics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Medical Biomimetics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies medical biomimetics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the medical biomimetics companies profiled in this report include-

  • Avinent
  • Biohorizons
  • Blatchford
  • Corneat Vision
  • Curasan
  • Keystone Dental
  • Osteopore International
  • Otsuka Medical Devices
  • Swedish Biomimetics
  • Zimmer Biomet

Medical Biomimetics Market Insights

Lucintel forecasts that dental is expected to witness highest growth over the forecast period due to increasing incidence of dental problems and the high adoption of dental biomimetics product.

Within this market, wound healing will remain the largest segment due to increasing number of surgical cases and rising prevalence of chronic diseases across the globe.

North America will remain the largest segment over the forecast period due to increasing dental issues necessitating the use of dental biomimetics products and heightened government funding for biomimetics product research.

Features of the Global Medical Biomimetics Market

Market Size Estimates: Medical biomimetics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Medical biomimetics market size by disease type, application, end use, and region in terms of value ($B).

Regional Analysis: Medical biomimetics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease types, applications, end uses, and regions for the medical biomimetics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the medical biomimetics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the medical biomimetics market size?

Answer: The global medical biomimetics market is expected to reach an estimated $56.6 billion by 2030.

Q.2 What is the growth forecast for medical biomimetics market?

Answer: The global medical biomimetics market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the medical biomimetics market?

Answer: The major drivers for this market are increasing government investment in biometrics research, coupled with the integration and advancement of mechanical engineering and nanotechnology in the healthcare sector.

Q4. What are the major segments for medical biomimetics market?

Answer: The future of the medical biomimetics market looks promising with opportunities in the hospital and specialty centre markets.

Q5. Who are the key medical biomimetics market companies?

Answer: Some of the key medical biomimetics companies are as follows:

  • Avinent
  • Biohorizons
  • Blatchford
  • Corneat Vision
  • Curasan
  • Keystone Dental
  • Osteopore International
  • Otsuka Medical Devices
  • Swedish Biomimetics
  • Zimmer Biomet

Q6. Which medical biomimetics market segment will be the largest in future?

Answer: Lucintel forecasts that dental is expected to witness highest growth over the forecast period due to increasing incidence of dental problems and the high adoption of dental biomimetics product.

Q7. In medical biomimetics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing dental issues necessitating the use of dental biomimetics products and heightened government funding for biomimetics product research.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the medical biomimetics market by disease type (cardiovascular, orthopedic, ophthalmology, dental, and others), application (wound healing, tissue engineering, drug delivery, and others), end use (hospitals, specialty centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Medical Biomimetics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Medical Biomimetics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Medical Biomimetics Market by Disease Type
    • 3.3.1: Cardiovascular
    • 3.3.2: Orthopedic
    • 3.3.3: Ophthalmology
    • 3.3.4: Dental
    • 3.3.5: Others
  • 3.4: Global Medical Biomimetics Market by Application
    • 3.4.1: Wound Healing
    • 3.4.2: Tissue Engineering
    • 3.4.3: Drug Delivery
    • 3.4.4: Others
  • 3.5: Global Medical Biomimetics Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Centres
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Medical Biomimetics Market by Region
  • 4.2: North American Medical Biomimetics Market
    • 4.2.2: North American Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others
  • 4.3: European Medical Biomimetics Market
    • 4.3.1: European Medical Biomimetics Market by Disease Type: Cardiovascular, Orthopedic, Ophthalmology, Dental, and Others
    • 4.3.2: European Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others
  • 4.4: APAC Medical Biomimetics Market
    • 4.4.1: APAC Medical Biomimetics Market by Disease Type: Cardiovascular, Orthopedic, Ophthalmology, Dental, and Others
    • 4.4.2: APAC Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others
  • 4.5: ROW Medical Biomimetics Market
    • 4.5.1: ROW Medical Biomimetics Market by Disease Type: Cardiovascular, Orthopedic, Ophthalmology, Dental, and Others
    • 4.5.2: ROW Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Medical Biomimetics Market by Disease Type
    • 6.1.2: Growth Opportunities for the Global Medical Biomimetics Market by Application
    • 6.1.3: Growth Opportunities for the Global Medical Biomimetics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Medical Biomimetics Market by Region
  • 6.2: Emerging Trends in the Global Medical Biomimetics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Medical Biomimetics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Medical Biomimetics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AVINENT
  • 7.2: BioHorizons
  • 7.3: Blatchford
  • 7.4: CorNeat Vision
  • 7.5: Curasan
  • 7.6: Keystone Dental
  • 7.7: Osteopore International
  • 7.8: Otsuka Medical Devices
  • 7.9: Swedish Biomimetics
  • 7.10: Zimmer Biomet